CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

89 hedge funds and large institutions have $133M invested in Concert Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
-5
Holders Change %
-5.32%
% of All Funds
2.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
33
Reduced
23
Closed
17
Calls
$110K
Puts
–
Net Calls
+$110K
Net Calls Change
-$30K

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$5.54M
2
ISL
2
Ingalls & Snyder LLC
New York
$11M
3
Millennium Management
3
Millennium Management
New York
$2.4M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$1.17M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$4.48M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
BFA
2
BlackRock Fund Advisors
California
$5.62M
3
SIM
3
Spark Investment Management
New York
$0
4
SAM
4
Senzar Asset Management
New York
$4.12M
5
BBA
5
Baker Bros. Advisors
New York
$1.57M
Name Holding Trade Value Shares
Change 		Shares
Change %
CCMH
101
Cornerstone Capital Management Holdings
New York
– -$36K -3,600 Closed
CSS
102
Cubist Systematic Strategies
Connecticut
– -$18K -1,783 Closed
Group One Trading
103
Group One Trading
Illinois
– -$10K -1,007 Closed
AG
104
Advisor Group
Arizona
– -$6K -575 Closed
CG
105
Cutler Group
California
– -$2K -200 Closed
PHK
106
Point72 Hong Kong
Hong Kong
– -$1K -100 Closed
1 2 3 4
5